Bangkok 18^th March, 2024 – Syneos Health^®, a leading fully integrated biopharmaceutical solutions organization, has signed an agreement with Faculty of Medicine Siriraj Hospital, Mahidol University. The agreement expands the Company’s clinical trial capabilities across a broad range of therapeutic areas in Thailand.

Siriraj Hospital now becomes part of the Syneos Health Catalyst and Site Network Partnerships program, including 110+ clinical sites and 60+ commercial site networks. As part of the Site Network Partnerships program, Siriraj Hospital joins a select set of high-performing investigative site networks strategically aligned to Syneos Health’s clinical studies. Site Network Partnerships provide enhanced patient access, improved efficiencies, specialized expertise and access to diverse patient populations across all therapeutic areas and phases.

“In medicine, as health care professionals, we are never satisfied: there is always a patient we want to help, always a disease we want to treat, always more we want to know to take the best decisions for patients and their families and care givers. This is why we work with so many around the world in the development of new treatments.

These treatments are for all patients in the world and ideally, they are developed with all patients in the world represented in clinical trials.

It is an exciting day today to formalize the collaboration between Siriraj hospital and Syneos Health. Together, we can open clinical trials for patients in Bangkok – offering treatment options that are not available today, while collecting data for the patients of tomorrow.

As this marks the finalization of several months of preparation in both organizations, it is the start of many further successful collaborations, now and in the future!” said Dr. Terttu Haring, President, Site & Patients.

                         (Left) Prof. Apichat Asavamongkolkul, Dean of the Faculty of Medicine Siriraj Hospital (Right) Dr. Terttu Haring, President, Site & Patients Syneos Health.

“We are thrilled to embark on this pivotal partnership with Syneos Health, a moment of significance in advancing efficient and effective clinical research capabilities in our region. Our Catalyst site’s ambition to establish itself at the forefront of Southeast Asia’s landscape for academic clinical research is immensely refined through this Catalyst program.” said Assoc. Prof. Winai Ratanasuwan, MD Director of Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University.

About the Faculty of Medicine Siriraj Hospital, Mahidol University

The Faculty of Medicine Siriraj Hospital is the oldest medical institute in Thailand. It was founded in 1888 by His Majesty the King Chulalongkorn. The institute seeks to produce high-quality medical graduates, research and publications, as well as medical services with international standards. The hospital’s mission is to improve the health and quality of life of Thais and the broader international community. www.2.si.mahidol.ac.th

About SICRES

The Siriraj Institute of Clinical Research (SICRES) is an academic clinical research institute that operates under the Faculty of Medicine Siriraj Hospital, Mahidol University. Our mission is to conduct and support clinical research trials to transform patient care, improve human health, and better the community. We conduct cost-effective clinical research at international standards and provide full-service clinical trial design and management. Our vision is to become the most trusted academic clinical research organization in Southeast Asia. www.sicres.org/

About Syneos Health

Syneos Health^® is a leading fully integrated bio-pharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.  

We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviour and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. 

Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.  

To learn more about how we are Shortening the distance from lab to life^®, visit syneoshealth.com.